Netherlands· NL-9b27cc070363

Bimatoprost Brown & Burk 0,3 mg/ml oogdruppels, oplossing, in verpakking voor eenmalig gebruik

A bimatoprost product containing bimatoprost, registered in Netherlands by Brown & Burk IR Limited. The same ATC class is registered in 19 of our 19 countries.

ATC S01EE03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about bimatoprostAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Bimatoprost is registered in 19 of 19 countries.

Countries holding a registration under ATC S01EE03 (bimatoprost), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search bimatoprost products by name

Bimatoprost · ATC S01EE03

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BIMATOPROST
Manufacturer: Brown & Burk IR Limited
Country: Netherlands (NL)
ATC code: S01EE03
ATC class: Bimatoprost
Defined daily dose: 0.1 ml, AT
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
127138

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for bimatoprost.

Graded by severity as the source publishes them — 89 info. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check bimatoprost against other medicines How interaction checks work

Bimatoprost · interactions on record

89 records

89 info

Most severe, free to view

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Bimatoprost in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bimatoprost products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Bima-Vision Sine, Bimato-Vision
Belgium · Bimatoprost Eg, Bimatoprost Eg (Eurogenerics)
Bulgaria · Бимаган, Биматопрост Абр
Cyprus · Bimatoprost Pharmathen, Birmost
Czechia · Bimatoprost Farmaprojects, Bimatoprost Olikla
Germany · Amiriox, Bimato-Vision
Denmark · Bimatoprost "hexal", Bimatoprost "stada"
Estonia · Elymbus
Spain · Amiriox, Bamixol
Finland · Bimatoprost, Bimatoprost Sandoz
France · Amiriox, Bimatoprost
United Kingdom (Northern Ireland) · Amiriox, Bimatoprost Alissa Healthcare Research
Greece · Birmost, Dacrysan
Croatia · Elymbus
Ireland · Elymbus, Eyreida
Iceland · Bimatoprost, Elymbus
Italy · Amiriox, Bialviz
Liechtenstein · Lumigan
Lithuania · Bimican, Bimifree
Luxembourg · Bimatoprost Eg, Bimatoprost Eg (Eurogenerics) Nv
Latvia · Bimican, Bimifre
Norway · Bimaprez, Bimatoprost Hexal
Poland · Bimican, Bimifree
Portugal · Amiriox, Bimatoprost Stulln
Romania · Amiriox, Bimagan
Sweden · Bimaprez, Bimatoprost
Slovenia · Elymbus
Slovakia · Bimatoprost Olikla, Elymbus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ef63bd34-934f-4f9f-8143-5bc3617949d7
GET /v1/drugs/ef63bd34-934f-4f9f-8143-5bc3617949d7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127138_smpc.pdf",
  "strength": null,
  "atc_label": "Bimatoprost",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127138",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "BIMATOPROST"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127138.pdf",
  "authorised_at": "2022/03/08",
  "procedure_number": "NL/H/5183/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127138",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about bimatoprost.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console